Skip to content

"The role of fat in symptom generation in patients with functional dyspepsia"

"The role of fat in symptom generation in patients with functional dyspepsia" - "Fat and dyspeptic symptoms"

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33884
Enrollment
25
Registered
2009-03-10
Start date
2009-04-09
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

indigestion Upper abdominal complaints

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18-65 years old Recurrent bothersome postprandial fullness, early satiation and/or epigastric pain At least 2 days per week for 3 months or more

Exclusion criteria

Exclusion criteria: Esophagitis Barrett's esophagus Peptic ulcer disease Prior gastrointestinal surgery Pregnancy Drug- or alcohol abuse Use of Aspirin in combination with Clopidogrel

Design outcomes

Secondary

MeasureTime frame
Differences in plasma and duodenal mucosal concentrations of apoA-IV and/or CCK between FD patients and healthy controls. Relationship between plasma and duodenal mucosal concentrations of apoA-IV and/or CCK upon duodenal lipid load and sensitivity to gastric distension and/or gastric emptying rate of FD patients.

Primary

MeasureTime frame
Differences in duodenal mRNA expression of genes, involved in the chylomicron-apoA-IV-CCK pathway, between FD patients and healthy controls. Relationship between duodenal mRNA expression of genes, involved in the chylomicron-apoA-IV-CCK pathway, upon duodenal lipid load and sensitivity to gastric distension and/or gastric emptying rate of FD patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)